| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 8.2e-05 | 1 |